Oncology
Contact admin @murtazakuchay for any Queries/promotion/copyright issue
Show more📈 Analytical overview of Telegram channel Oncology
Channel Oncology (@oncology_vid) in the English language segment is an active participant. Currently, the community unites 17 520 subscribers, ranking 1 340 in the Medicine category and 23 336 in the India region.
📊 Audience metrics and dynamics
Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 17 520 subscribers.
According to the latest data from 06 September, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by -6 over the last 30 days and by -13 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 159.84%. Within the first 24 hours after publication, content typically collects 10.16% reactions from the total number of subscribers.
- Post reach: On average, each post receives 28 013 views. Within the first day, a publication typically gains 1 781 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 2.
- Thematic interests: Content is focused on key topics such as tumor, gist, marker, cell, medicine.
📝 Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
“Contact admin @murtazakuchay for any Queries/promotion/copyright issue”
Thanks to the high frequency of updates (latest data received on 07 September, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.
DCTRXNSQ*
⚡ High-yield video lectures
⚡ Every topic tagged with PYQs from NEET PG, FMGE & INI-CET
😱 *DON'T FORGET TO CLICK THE LINK FOR FREE ACCESS* 👇
https://prepladder.com/app/rapid-revision-XI-videos-391--DCTRXNSQ
Best discount code: *DCTRXNSQ*
_This is your chance to experience Rapid Revision before the real deal begins_